Cite
HARVARD Citation
Hanania, N. et al. (2016). Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. Lancet. 4 (10), pp. 781-796. [Online].